Chris Jackson

Professor Chris Jackson is an Honorary Professor of Regenerative Science and Medicine at the Kolling Institute, Northern Clinical School, Faculty of Medicine and Health, University of Sydney, a position he has held since 2021. He previously served as Professor of Regenerative Science and Medicine in the Northern Clinical School from 2013 to 2020 and as Associate Professor from 2006 to 2013. Jackson earned his PhD from the University of Sydney and was Director of the Sutton Arthritis Research Laboratory at Royal North Shore Hospital from 1999 to 2020. His academic career includes appointments in the Medical School and Department of Medicine at the University of Sydney. As Chief Investigator, he has secured over $16 million in research grants from prestigious funders including the National Health and Medical Research Council (NHMRC), Arthritis Australia, Juvenile Diabetes Research Foundation International, Health Research Council New Zealand, Korea National Research Foundation, Lincoln Centre, and Ramsay Health.

Jackson's research focuses on autoimmune and inflammatory conditions, with particular emphasis on inflammatory skin conditions, rheumatoid arthritis, and chronic wound healing. He discovered the regenerative capacity of activated protein C (APC), demonstrating its potent anti-inflammatory and wound-healing effects through novel biochemical and molecular techniques in preclinical models. This bench-to-bedside approach progressed to proof-of-principle clinical trials in collaboration with clinicians at Royal North Shore Hospital, successfully treating over 50 patients with recalcitrant chronic wounds, many achieving complete healing. Ongoing initiatives include large-scale trials for diabetic ulcers and development of APC-mimicking peptides via co-founded biotech company Novapep. Key publications include 'Inflammation in Chronic Wounds' (2016, International Journal of Molecular Sciences), 'Activated Protein C in Cutaneous Wound Healing: From Bench to Bedside' (2019, International Journal of Molecular Sciences), and 'Treatment of Chronic Leg Ulcers With Topical Activated Protein C' (2008, Archives of Dermatology). With over 130 peer-reviewed publications, his work has advanced regenerative medicine, leading to patents and commercial applications in wound care.

Professional Email: chris.jackson@sydney.edu.au